Research graph
References from Collaborative effects of 2019-nCoV-Spike mutants on viral infectivity. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s2213-2600(20)30076-x
10.1016/s2213-2600(20)30076-x · External reference
10.1056/nejmoa2102214
10.1056/nejmoa2102214 · External reference
10.1016/s0140-6736(20)32466-1
10.1016/s0140-6736(20)32466-1 · External reference
10.1001/jama.2020.15543
10.1001/jama.2020.15543 · External reference
10.1016/s1473-3099(20)30843-4
10.1016/s1473-3099(20)30843-4 · External reference
COVID antiviral pills: what scientists still want to know
10.1038/d41586-021-03074-5 · 2021 · External reference
How antiviral pill molnupiravir shot ahead in the COVID drug hunt
10.1038/d41586-021-02783-1 · 2021 · External reference
10.1126/science.abe8499
10.1126/science.abe8499 · External reference
10.1016/j.cell.2021.02.033
10.1016/j.cell.2021.02.033 · External reference
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
10.1038/s42003-021-02728-4 · 2021 · External reference
SARS-CoV-2 variants are selecting for Spike protein mutations that increase protein stability
10.1021/acs.jcim.1c00990 · 2021 · External reference
Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C
10.1038/s41392-021-00695-0 · 2021 · External reference
New variant of SARS-CoV-2 in UK causes surge of COVID-19.
10.1016/s2213-2600(21)00005-9 · 2021 · External reference
10.1126/science.abf9302
10.1126/science.abf9302 · External reference
10.1038/s41586-020-2180-5
10.1038/s41586-020-2180-5 · External reference
10.1038/s41579-021-00573-0
10.1038/s41579-021-00573-0 · External reference
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
10.1126/science.abc5881 · 2020 · External reference
An online coronavirus analysis platform from the National Genomics Data Center
10.24272/j.issn.2095-8137.2020.065 · 2020 · External reference
Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species
10.1093/bib/bbaa329 · 2020 · External reference
In silico prediction of new mutations that can improve the binding abilities between 2019-nCoV coronavirus and human ACE2
10.1109/tcbb.2021.3058265 · 2021 · External reference
10.1002/jcc.20084
10.1002/jcc.20084 · External reference
10.1002/prot.24551
10.1002/prot.24551 · External reference
10.1021/ct200909j
10.1021/ct200909j · External reference
10.1038/s41586-020-2008-3
10.1038/s41586-020-2008-3 · External reference
10.1080/22221751.2020.1743767
10.1080/22221751.2020.1743767 · External reference
A simple method of estimating fifty-percent endpoints
10.1093/oxfordjournals.aje.a118408 · 1938 · External reference
